Skip to main content
Log in

Expression of MMIF, HIF-1α and VEGF in Serum and Endometrial Tissues of Patients with Endometriosis

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

The aim of this study was to investigate the expression of macrophage migration inhibitory factor (MMIF), hypoxia-inducible factor-1 a (HIF-1α) and vascular endothelial growth factor (VEGF) in the serum and endometrial tissues of patients with endometriosis (EM) and the clinical significance. Eighty EM patients [American Reproductive Association stage I (n=20), stage II (n=22), stage III (n=21) and stage IV (n=17)] were enrolled and divided into mild (10-14 points, n=28), moderate (16-24 points, n=27) and severe (26-30 points, n=25) dysmenorrhea groups. The control group included 40 healthy women of childbearing age who underwent routine healthcare examinations in the enrolment period. The expression of MMIF, HIF-1α and VEGF in the serum and endometrial tissues was measured by enzyme-linked immunosorbent assay and Western blotting, respectively. Meanwhile, the sensitivity and specificity of serum MMIF, HIF-1α, and VEGF when separately used as single indexes or jointly used as one index were examined as well. The results showed that serum concentrations of MMIF, HIF-1α, and VEGF were significantly higher in EM patients than in controls (P<0.05). The expression of all three proteins in both serum and endometrial tissues increased significantly with the R-AFS stage (P<0.05) and with dysmenorrheal severity (P<0.05). The sensitivity and specificity of the combined detection of serum MMIF, HIF-1α, and VEGF levels were significantly higher than those of single index detection (P<0.05). In conclusion, the expression of MMIF, HIF-1α, and VEGF in the serum and endometrial tissues may be used to assess the stage of EM and the severity of dysmenorrhea. Combined evaluation of MMIF, HIF-1α, and VEGF significantly improves the diagnostic sensitivity and specificity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Psaroudakis D, Hirsch M, Davis C. Review of the management of ovarian endometriosis: paradigm shift towards conservative approaches. Curr Opin Obstet Gynecol, 2014,26(4):266–274

    Article  PubMed  Google Scholar 

  2. Dancet EA, Apers S, Kremer JA, et al. The patientcenteredness of endometriosis care and targets for improvement: a systematic review. Gynecol Obstet Invest, 2014,78(2): 69–80

    Article  PubMed  Google Scholar 

  3. Veillat V, Sengers V, Metz CN, et al. Macrophage migration inhibitory factor is involved in a positive feedback loop increasing aromatase expression in endometriosis. Am J Pathol, 2012,181(3):917–927

    Article  PubMed  CAS  Google Scholar 

  4. Serrano-Oviedo L, Giménez-Bachs JM, Nam-Cha SY, et al. Implication of VHL, ERK5, and HIF-1 alpha in clear cell renal cell carcinoma: Molecular basis. Urol Oncol, 2017,35(3):el5–e22

    Article  CAS  Google Scholar 

  5. Xu H, Zhang T, Man GC, et al. Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis. Angiogenesis, 2013,16(3):541–551

    Article  PubMed  CAS  Google Scholar 

  6. Stilley JA, Birt JA, Sharpe-Timms KL. Cellular and molecular basis for endometriosis-associated infertility. Cell Tissue Res, 2012,349(3):849–862

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Gregoric P, Doklestic K, Pandurovic M, et al. Distal ideal endometriosis as a cause of ileus: a case report. Srp Arh Celok Lek, 2012,140(3-4):225–228

    Article  PubMed  Google Scholar 

  8. Mei J, Xie XX, Li MQ, et al. Indoleamine 2, 3-dioxygenase-l (IDOl) in human endometrial stromal cells induces macrophage tolerance through interleukin-33 in the progression of endometriosis. Int J Clin Exp Pathol, 2014,7(6):2743–2757

    PubMed  PubMed Central  CAS  Google Scholar 

  9. Pirdel L, Pirdel M. Role of iron overload-induced macrophage apoptosis in the pathogenesis of peritoneal endometriosis. Reproduction, 2014,147(6):R199–R207

    Article  PubMed  CAS  Google Scholar 

  10. Lin W, Chen S, Li M, et al. Expression of macrophage migration inhibitory factor in human endometriosis: relation to disease stage, menstrual cycle and infertility. J Obstet Gynaecol Res, 2010,36(2):344–351

    Article  PubMed  CAS  Google Scholar 

  11. Pan X, Mao X, Cheng T, et al. Macrophage migration inhibitiory factor: a regular of MMP13 and inflammation in titanium particles stimulated air pouch in vivo. Mol Cell Biochem, 2011,357(1-2):313–321

    Article  PubMed  CAS  Google Scholar 

  12. Baron N, Deuster O, Noelker C, et al. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells. J Neurosci Res, 2011,89(5):711–717

    Article  PubMed  CAS  Google Scholar 

  13. Ajdukovic J. HIF-l-a big chapter in the cancer tale. Exp Oncol, 2016,38(1):9–12

    PubMed  CAS  Google Scholar 

  14. Eslavath RK, Sharma D, Bin Omar NA, et al. P-N-oxalyl-L-a, P-diaminopropionic acid induces HRE expression by inhibiting HIF-prolyl hydroxylase-2 in normoxic conditions. Eur J Pharmacol, 2016,791:405–411

    Article  PubMed  CAS  Google Scholar 

  15. Li J, Mi C, Ma J, et al. Dihydrotanshinone I inhibits the translational expression of hypoxia-inducible factor-la. Chem Biol Interact, 2015,240(5):48–58

    Article  PubMed  CAS  Google Scholar 

  16. El-Naggar AM, Veinotte CJ, Cheng H, et al. Translational activation of HIF1α by YB-1 promotes sarcoma metastasis. Cancer Cell, 2015,27(5):682–697

    Article  PubMed  CAS  Google Scholar 

  17. Critchley HO, Osei J, Henderson TA, et al. Hypoxiainducible factor-1 alpha expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2(EP2). Endocrinology, 2006,147(2):744–753

    Article  PubMed  CAS  Google Scholar 

  18. Goteri G, Lucarini G, Zizzi A, et al. Proangiogenetic molecules, hypoxia-inducible factor-1 alpha and nitric oxide synthase isoforms in ovarian endometriotic cysts. Virchows Arch, 2010,456(6):703–710

    Article  PubMed  CAS  Google Scholar 

  19. Wu MH, Lu CW, Chang FM, et al. Estrogen receptor expression affected by hypoxia inducible factor-la in stromal cells from patients with endometriosis. Taiwan J Obstet Gynecol, 2012,51(2):50–54

    Article  PubMed  Google Scholar 

  20. Kim KH, Kim HY, Kim HH, et al. Hypoxia induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human endometrial cells. Mol Hum Reprod, 2011,17(3):710–719

    Article  PubMed  CAS  Google Scholar 

  21. Hsiao KY, Chang N, Lin SC, et al. Inhibition of dual specificity phosphatase-2 by hypoxia promotes interleukin-8-mediated angiogenesis in endometriosis. Hum Reprod, 2014,29(2):2747–2755

    Article  PubMed  CAS  Google Scholar 

  22. Courtnay R, Ngo DC, Malik N, et al. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep, 2015,42(5):841–851

    Article  PubMed  CAS  Google Scholar 

  23. Denko NC. Hypoxia HIFI and glucose metabolism in the solid tumour. Nat Rev Cancer, 2008,8(2):705–713

    Article  PubMed  CAS  Google Scholar 

  24. Cho S, Choi YS, Jeon YE, et al. Expression of vascular endothelial growth factor (VEGF) and its soluble receptor-1 inendometriosis. Microvasc Res, 2012,83(2):237–242

    Article  PubMed  CAS  Google Scholar 

  25. Leone R Maggiore U, Ferrero S. Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of women with endometriosis. Int J Fertil Steril, 2015,8(4):485–486

    Google Scholar 

  26. Fang F, Gong L, Wang X, et al. The association between vascular endothelial growth factor (VEGF) +405G&gt;C genetic polymorphism and endometriosis. Exp Biol Med, 2015,240(9): 1177–1182

    Article  CAS  Google Scholar 

  27. Gonçalves GA, Camargo-Kosugi CM, Bonetti TC, etal. p27kipl overexpression regulates VEGF expression, cell proliferation and apoptosis in cell culture from eutopic endometrium of women with endometriosis. Apoptosis, 2015,20(3):327–335

    Article  PubMed  CAS  Google Scholar 

  28. Huang F, Wang H, Zou Y, et al. Effect of GnRH-II on the ESC proliferation, apoptosis and VEGF secretion in patients withendometriosis in vitro. Int J Clin Exp Pathol, 2013,6(ll):2487–2496

    PubMed  PubMed Central  Google Scholar 

  29. Li YZ, Wang LJ, Li X, et al. Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies. Genet Mol Res, 2013,12(2): 1035–1044

    Article  PubMed  CAS  Google Scholar 

  30. Barcz E, Milewski L, Dziunycz P, et al. Peritoneal cytokines and adhesion formation in endometriosis: an inverse association with vascular endothelial growth factor concentration. Fertil Steril, 2012,97(6): 1380–1386

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li-ping Liu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, F., Liu, Xl., Wang, W. et al. Expression of MMIF, HIF-1α and VEGF in Serum and Endometrial Tissues of Patients with Endometriosis. CURR MED SCI 38, 499–504 (2018). https://doi.org/10.1007/s11596-018-1906-1

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-018-1906-1

Key words

Navigation